Upcoming Events

SMi is delighted to announce its Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21st - 22nd October 2019.

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure worker safety.

The event will explore how the latest technologies can benefit HPAPI with artificial intelligence and machine learning to hasten risk assessment and validation. We will also be dedicating much deserved attention on emerging HPAPI therapies including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? Come and find the answers to these hot topics of HPAPI along with the other unique insights such as continuous HPAPI manufacturing technologies.

Attend this conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.

The inaugural Macrophage-directed Therapies Summit is the only platform dedicated to helping leaders from pharma, biotech and academic institutes to successfully achieve clinical proof of concept when translating macrophage therapies into the clinic whilst ensuring safety, control and effective combination therapies.

Join your macrophage community and discuss strategies to characterize macrophage biology to understand their role in tumor progression and improve targeting precision to prevent off-tumor toxicities.

Network and learn from the trailblazers of macrophage therapeutic development including Carisma Therapeutics, Merck and ALX Oncology across 3 days packed with dedicated, interactive formats exploring the drug development of CD47 checkpoint blockades, engineered macrophages as well as macrophage repolarization and depletion.

The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations, Facility Management, Lab Supplies and Procurement across pharma, biotech, CROs and research institutions.

Join your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency.

As the drug discovery opportunity promised within the proteome becomes a reality and previously “undruggable” targets are reached, the 2nd TPD Summit  returns for 2019. This premier event exists not only to drive forward the translation of first generation of PROTACS and molecular glues into the clinic, but to  stimulate the discussion of next generation protein degraders that harness different modalities, target highly desirable targets and capitalize on degradation pathways, beyond the ubiquitin proteasome system.

The 3rd Annual Combination Products Forum 2019 will focus on the entire product lifecycle management process: From planning, design and implementation, right the way through to post-market maintenance and surveillance strategies.

Through a range of interactive workshops, panel discussions, roundtables and case study presentations, key topics will focus on device development, navigating the regulatory landscape, the EU MDR 2020, change management and departmental alignment, product usability, human factors, post-market surveillance and general management across the total product lifecycle becoming critical.

Now in its 2nd year, the industry-focused Neuromuscular Drug Development Summit (NMD) will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market.

Pharma Formulations 2019 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about formulations and drug delivery and its advances. This is your best opportunity to reach the largest assemblage of participants from Pharma research community that is from academia, drug delivery entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Pharma Formulations 2019 will discuss various disciplines involved in the drug formulation procedures and drug delivery technologies; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of formulations. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new pharma research developments, and receive name recognition at this 2-days event. World renowned speakers and the most recent techniques, developments, the newest updates in formulations and drug delivery are hallmarks of this conference.

Understanding key factors behind investigator-initiated research is highly important for successfully answering important medical and scientific questions, which will uncover solutions to unmet therapeutic needs. These solutions can lead to a successful study that can improve patient care and spark new ideas for further disease-related research that will produce improved medicines for people who need them.

The Investigator-Initiated Trials (IIT) Forum covers all aspects of IITs, including the use of performance measures to optimize trials, considerations for running single vs. multicenter trials, best practices for understanding and fulfilling the expectations of industry and sponsors, structured data, analytics and systems management impact on IITs, and ways to foster compliance and strengthen studies for newer sponsor-investigators.

In addition, this forum speaks to the similarities and differences between research collaborations and IITs, including responsibilities; ownership of the research, royalties and publication rights; and, most crucially, when it’s viable and appropriate to support each type of collaboration.

Join us in Philadelphia and return to work armed with the necessary tools and techniques you need to be successful in managing the pursuit of trials that can lead to new and improved therapies and the discovery of new drug indications.

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.

SAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers, with a range of exhibitors from across the pharmaceutical sector.

Don’t miss out on your chance to participate at this event.

It is our great pleasure to invite you to participate in the 34th International Conference on Advanced Pediatrics and Neonatology (ADV. Pediatrics 2019), which will take place 24th and 25th October 2019 in Zurich, Switzerland.

The main objective of the conference is to bring together pediatricians, neonatologists, experts in child development and other specialists to exchange their ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations.

Healthcare in the GCC region has always aimed to be a pioneer in establishing a sustainable patient-centric Model that follows the highest international standards. Pharmacists are at the forefront of this strategic direction and their vital role in patient care and pharmaceutical advancement is always a key contributor to the effective execution of personalized patient models.

The 6th Annual GCC Pharmacy Congress provides an excellent opportunity to network and engage with top tier regional experts as well as esteemed speakers from across the GCC region whom will share their expertise and engage in a productive dialogue that will enhance the overall scientific exchange experience.

The scientific program of the Congress is tailored according to the individual needs and interests of hospital and community pharmacists, as it offers the possibility to choose between two parallel streams with keynote presentations and workshops. This year we also provide “Pharmaceutical Supply Chain Symposium” which will offer in-depth analysis of the current challenges, whilst exploring alternative strategies and solutions.

We are confident that you will enjoy this year’s dedicated tracks and gain amplified knowledge from the conference that is highly beneficial to apply in your practice.

Over 350 delegates representing leading biotechnology companies, global pharmaceutical organisations, and internationally renowned academic institutions.

Over 30 presentations, case studies and panel discussions focussed on Cell & Gene Therapy development and clinical research, the commercialisation of CAR T treatments, and Cell & Gene Therapy bioprocessing and manufacturing strategies.

Join over 150 delegates from from internationally renowned academic institutions global pharmaceutical organisations and leading biotech companies

Over 20 presentations and case studies focusing on the discovery of stem cells in regenerative medicine, manufacturing innovations in clinical trials and bioprocessing methods in cell line development.

Over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

In a rapidly advancing technology for cardiac surgeries and treatments, the time has come to move forward with cutting edge strategies to maximize their performance. Cardiology World Conference 2019 driven by the theme “Advances in Cardiology: Research and Innovations” has been designed to minimize the Mortality rate occurred by cardiac diseases, while maximizing the depth of true peer-to-peer discussions.

CWC 2019 is one of the leading cardiology conferences, which discusses the current innovations & technology trends in Cardiac Surgery, Cardiac Care, Cardio-Oncology, Cardiovascular Nursing and Interventional Cardiology. The event takes place on October 24-25, 2019 at Radisson Hotel Narita, Tokyo, Japan featuring the world class speakers presenting case studies in their work through enlightening keynotes, oral and poster presentations, interactive networking activities and workshops.

Aim of the conference: The main goal of CWC 2019 is to advance the cardiology research and innovations and to promote its objectives. It contributes significantly to the scientific development of cardiology and evolves subspecialty that incorporates on-going research in the clinical application. This is a major platform for promoting & improving results, and advancing cardiology in its dynamic field.

We look forward to seeing you in Tokyo, Japan.

Pharmaist Exhibition, where the latest products and technologies of the industry will be showcased is characterized as a unique platform to serve as a venue for the industry’s purchases related to chemicals, raw materials, ingredients and technologies in Turkey. The pharmaceutical industry which is one of the most important sub-branch of chemical sector, has a rapid growth momentum in the world and it continues its development in terms of production capacity and technology in Turkey as well. The industry, which has a direct impact on human health within the scope of life sciences, has a strategic position with its high R&D globally.

Over 30 presentations will be given at the 2019 meeting. This year the meeting is focused on how you can successfully leverage the power of AI and machine learning by utilising high-quality big data in order to revolutionise your drug discovery and development process. Talks will explore implementation strategies and advances in the convergence of AI, informatics and data management for early drug discovery.

As many blockbuster products face the loss of exclusivity, life science organizations face staunch competition from generic and biosimilar products to maintain their stronghold in certain markets. There is a lot riding on the success of new drug development, and companies are increasingly turning to external sources of innovation to supplement organic pipeline growth and replace key products within their portfolios.

Biotechs continue to push the boundaries of R&D innovation, exploring specialized areas of research, often entering undefined, first-in-class territory. However, changing regulatory requirements, payer expectations, and investor demands make drug development and commercialization an increasingly risky endeavor, leaving little to no margin for error. It takes strong leadership, a well-articulated and communicated shared vision, and innovative partnerships to navigate the competitive landscape and ensure the successful development of a commercially viable product in today’s healthcare environment.

FierceBiotech’s 4th Drug Development Forum features executive leadership perspectives from biotech and big pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend and unlock the potential of a licensing, joint venture or M&A deal.

CBI’s eCOA/ePRO 2019 stays on the pulse of the increasing utilization of BYOD, mobile devices, sensors, wearables and other innovative technologies in clinical trial data collection. This interactive conference provides the opportunity for peer-to-peer benchmarking and in-depth sessions for actionable takeaways related to the use of technology to support clinical trials and high quality data collection.

The 4th ERPA Annual Congress on Regulations and Compliance for Cosmetics (CRCC2019) taking place 28-29 October 2019 in Brussels, Belgium.

Following the success of the Congress in Prague in 2016, Berlin in 2017 and Brussels in 2018, at this forth Congress you will have the opportunity to acquire expert knowledge and learn groundbreaking news about the European cosmetics regulatory framework. The congress will cover as well the Brexit aftermath focusing on practical actions needed to enter or remain on the UK market.

The potential to target the inflammasome as a therapeutic for many diseases is huge, with rapid advances and excitement in the field, now is the time combine forces and help accelerate development of truly curative inflammasome therapeutics.

The inaugural Inflammasome Therapeutics Summit (ITS) is industry’s first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing. With the mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases.

With the goal of making medicine safe for people all over the world, there are few issues more important than drug safety. And while predicting the future is still impossible, technological developments continue to make it possible to be vigilant across the globe in this industry.

To discuss this and more, we are pleased to invite you to the 5th Pharmacovigilance & Drug Safety Summit on Oct. 30-31, 2019, in Berlin, Germany. The two-day event will bring together top professionals working on the latest trends to be both proactive and predictive in PV and drug safety in Europe as well as developing countries. Technologies like AI and automation will continue to transform what’s possible in the industry, and even social media has the potential to be a transformational tool in PV. Furthermore, attendees will hear real-world examples of advanced data management systems, real-time drug safety analysis and developing an effective PV audit strategy with a business partner.

Don’t miss this opportunity to learn from experts and to network with managers, vice presidents, directors and C-Suite executives who work in PV and drug safety. We look forward to welcoming you in Berlin this October!

Lab Innovations is the UK’s largest annual trade exhibition dedicated to the entire laboratory industry, uniting +3,000 laboratory decision makers with +150 laboratory suppliers and manufacturers across all sectors.

Here you can source innovative new technologies, network with peers and earn CPD points in the free-to-attend conference programme. Supported by some of the UK’s top science institutions, it is a key event for powering the business of science.

If you're looking to source new technologies, future-proof your laboratory, and learn how to keep laboratory procurement sustainable - this is a must-attend event for you!

Procurement Success Summit is Asia’s premier event for procurement & supply chain leaders. As previous years, the annual PSS summit is dedicated to providing the attendees with an outstanding conference experience. PSS2019 will bring together 300+ procurement executives from different industries to Shanghai and discuss the latest trends, challenges, best practices. Don’t miss out the big gathering!

Join a global network of supply chain professionals and discover:

•  How to implement innovative technologies, transformation strategies and collaboration methods to enhance the efficiency of your supply chain processes
•  Agile customer-centric supply planning and optimisation strategies
•  With the current skills gap being faced by the industry, find out how to drive change through leadership, increase employee engagement and hands-on solutions to employee retention
•  How to manage risk and volatility in an ever-changing global economy
•  Disruptive technologies for managing supply, production and delivery; Big Data, IoT and Robotics
•  The use of analytics to interpret complexity demand information in omni-channel market
•  How to work across silos: realising the synergies and maximising the opportunities

Toxicology 2019 offers a unique platform to present research work and know the latest updates with a complete approach to diverse areas of interest.

Toxicology 2019 is designed to meet the needs of both experienced and new career professionals.

The Toxicology Conference provides a platform to make great professional contacts, and leave the conference with takeaways that will immediately elevate your performance and success by defining your path and managing your successful and profitable entrepreneurial/academic journey.

At Toxicology 2019, you can meet experts in the field Toxicology, Pharmacology, Eco-Toxicology, Risk Assessment, Environmental Chemistry, Pathology and Biochemistry. Listening to keynote presentations at the conference will inform you of the current research and innovations in the field of Environmental Toxicology and Pharmacology and will inspire research ideas of your own and will expose you to different styles of presentation.

Digital Therapeutics represents an opportunity to capitalize on technology and efficiency while delivering an elevated standard of care to patients. The innovation of digital therapeutics will enable the population to monitor and manage their healthcare as well as prevent diseases and improve their patient outcomes. This is a critical time for the industry as guidelines are put in place and best practices are being developed. In order to advance the industry, it is critical for digital therapeutics owners, healthcare providers, payers and pharmaceutical organizations to come together and create mutually beneficial partnerships.

The Digital Therapeutics Strategic Partnerships Summit is designed to be a meeting of the stakeholders, featuring real case-studies and lessons learned, to foster collaboration and ensure a common goal is defined. The goal of this Summit is to provide tangible resources while discussing standards for regulatory pathways, the benefits of strategic partnerships, and the importance of data sharing and governance. The Summit will focus on collaborating, educating and strategizing as an industry.

The world's largest pharmaceutical exhibition, CPhI Worldwide houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting over 45,000 visiting attendees and 2,500 international exhibitors, CPhI Worldwide is the place to network and source cost-effective pharma solutions from all over the world - in just 3 days, under one roof.

INCREASE PRODUCTIVITY AND QUALITY TO ACCELERATE YOUR BIOLOGICS AND NOVEL MOLECULES TOWARDS COMMERCIAL SUCCESS

Apply practical case studies from global mammalian and microbial experts working across upstream, downstream, industry 4.0, bioanalytics and manufacturing facility design

The World Hospital Congress of the International Hospital Federation (IHF) dates back to 1929, when it was first held in Atlantic City, USA as a biennial event. Since 2015 it has been held annually across the globe.

The Congress is a unique global forum that brings together leaders of national and international hospital and healthcare organizations to discuss key drivers of national and international policy, management, financial trends and solutions in healthcare management and service delivery. Through this forum, multidisciplinary exchange of knowledge, expertise and experiences are facilitated, together with dialogue on best practices in leadership in hospital and healthcare management and delivery of services.

IHF member organizations have various opportunities to showcase their accomplishments to peers and the rest of the global healthcare community. The event contributes to the enhancement and enrichment of knowledge and skills of healthcare professionals. The delegate make-up reflects the IHF membership which spans more than 50 countries.

The IHF World Hospital Congress is a one-stop shop for the healthcare professional seeking the opportunity and environment in which to engage in a 360-degree learning and knowledge-sharing experience among peers.

The 43rd IHF  World Hospital Congress is being hosted by the Ministry of Health of the Sultanate of Oman on 7-9 November 2018 in Muscat.

The 15th Pharma Meeting Pros Summit moves to Atlantic City! Join us at Harrah’s Waterfront Conference Center for the 2019 event. All Corporate and Third-Party Planners receive complimentary hotel accommodations! You’ll be asked for your arrival and departure dates at the hotel when you register for the conference.

ExL’s Pharmaceutical Meeting Professionals Summit is the established annual gathering for the pharmaceutical, biotechnology and medical device industry meeting and event executives. This summit delivers a research-based educational program attracting a balanced audience of both planners and suppliers in an intimate, relaxed setting, ideal for engaging and networking. Offering a selection of educational sessions, results-driven case studies, interactive panels, and intimate roundtables, the event provides a comprehensive and quality education on industry trends and critical topics necessary to optimize meeting management in the life science industries. Join us this November in New Jersey at this unique and engaging summit and leave with the knowledge and contacts necessary to advance your meeting operations.

Meridian Clinical Trial’s team works unconditionally to organize the industry’s best gathering for Pharma-Biotech and Clinical Research Organizations. 2nd Meridian Clinical Trials is an effective tool to increase organization’s overall performance, knowledge, and industry influence. The platform represents best local CROs, pharmaceutical, and biotechnology companies. The agenda focuses on Early Clinical Development, Clinical Outsourcing, Clinical Operations and Development, Patient Centric approach, Clinical Monitoring, Siteless Clinical Trials, best available technologies and artificial intelligence in conducting clinical trials.

2nd Meridian Clinical Trials is offering collaboration opportunities for local CROs who are well trusted for accelerating clinical pipelines without interventions. The Platform is a combination of Case study Presentations, high interactive Workshops, informative Panel Discussion, and face to face meetings.

The leading Competitive Intelligence event for Pharma and Biotech in Europe is already in the US and going into the second edition. Pharma CiMi.CON 2019 is an annual international knowledge & project exchange platform bringing together 120+ competitive and market intelligence professionals for networking and exchange, to discuss key industry topics and to create new partnerships. The event, which is collocated with CiMi.CON Evolution, provides you with precise insights into new business prospects and technical strategies, while offering the chance to discuss specific roadmaps for your CI & MI projects.

The World Anti-Microbial Resisitance Congress brings together all the stakeholders involved in developing new antimicrobial drugs and diagnostics.

The event focusses on one of the most important challenges currently facing the global healthcare sector: tackling scientific and economic issues around antimicrobial resistance.

ISOPT Clinical, Retina Chapter is the meeting for those who are interested in clinical research, those who wonder how drugs are developed, appreciate the opportunities and limitations of new technologies, the industry and those who would like to collaborate with it.

Over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies

Over 90 case studies and presentations focused on the developments in NGS technologies, NGS data analysis as well as clinical applications & diagnostics of NGS

Discover critical updates in the use of next generation sequencing and genomic technologies. Benefit from insights gained from the role of DNA sequencing on genome biology, population genetics and whole genome sequencing.

Learn more about NGS in pharma: Biomarker development, precision medicine and clinical diagnostics. Case studies include: NGS in drug discovery and development, biomarkers for precision therapies clinical genomics in immunotherapy, oncology, infectious and hereditary diseases as well as pre-natal genetic testing

NGS and genomics in healthcare: Discuss the use of latest NGS and Genomic technologies in patient care, diagnosis and therapeutic development, clinical diagnostics development, informatics and high-throughput sequencing & profiling

Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies

Over 20 case studies and presentations focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.

Including 2 interactive streams:

•  Genome Editing Techniques and Technologies
•  Therapeutic Applications of Genome Editing

Genetic Engineering 2019 collaborates all researchers, students, academicians, Industrialists around the world to participate in the CPD accredited International Conference on  Molecular Biology and Genetic Engineering which will be scheduled during November 07-08, 2019 at Melbourne, Australia that correlates Oral Presentation, Poster and E-Poster Presentation, Workshops, Symposiums and Exhibition.

Molecular Biology and Genetic Engineering conference targets attendees from both industrial and academic fields. Directors, Presidents/Vice Presidents, CEO, Professors, Emeritus professors, Associate and Assistant professors, Research Scholars, Students, Laboratory Technicians and other members from the related field.

The DocRoSh Global Solutions® organizing a global conferences first of its kind on the Global Pharmaceutical Industry topics to bring knowledge on Innovations, discoveries, Novel & Advance Technologies, Latest Trend, Competitions and Market Dynamics. The conference is going to be held on 9th November, 2019 at HILTON MUMBAI INTERNATIONAL AIRPORT The theme of the Summit is “Innovation, Technologies, Trends and Future of Pharma Industry Globally” with focused objective to provide opportunity to showcase & enhance scientific developments, discoveries, industry growth as well as to promote the highest standards of Pharmaceutical Industry practices. The programme would equip and establish a strong corporations & linkage between the industry- academia professionals around the world.The “1st Global Pharma Summit 2K19” would cater more than 150 participants with 1 Round Table Discussion, 5 Panels, and 30+ Speakers. The professionals are researchers, scientist, key decision-makers, industry experts, veterans, and academicians from different parts of the world.

The Critical Care Canada Forum is a world-renowned meeting for professionals involved with the care of critically ill patients. The Forum focuses on leading-edge science through informative and interactive sessions, lead by an outstanding global faculty. The scientific program is ultra current and includes plenaries, panel presentations, specialty workshops, hands-on courses, Fellows Day, oral and poster presentations plus exhibits showcasing the latest products and services for the critical care professional.

In the past years, companies have increased their focus on the oversight and prevention of potential risks impacting individual clinical studies or the overarching clinical program success by means of subject well-being and protection, data quality and site performance as well as accuracy and correctness of final study results.

This change in perspective has been encouraged by regulatory authorities with both FDA and EMA guidelines released in 2013 for risk-based quality management of clinical investigations and with the release, in 2016, of the integrated addendum to the ICH E6 guideline, specifically addressing the need for a quality management system using a risk-based approach.

Euroscicon heartily welcomes every one of the members from everywhere throughout the globe to attend the " 32nd World Pediatrician Congress" which will be held amidst November 11-12, 2019 at Sydney, Australia, concentrating on scientific excellence, valuable to both industrialists and academicians. It includes prompt keynote introductions, oral presentations, publication introductions and displays. The topic of the present year's meeting is " Novel approaches of paediatrician towards child's health", which will give an international stage to talk about present and future difficulties in different points of sustenance, for example, General Pediatrics, Neonatology and Perinatology, Pediatric Infections, Pediatric Epilepsy, Pediatric Sleep Medicine, Pediatric Resuscitation, Pediatric Case Report etc.,.

BABE 2019 welcomes attendees, presenters, and exhibitors from all over the world to London. We are delighted to invite you all to attend and register for the “World Congress on Bioavailability and Bioequivalence” which is going to be held during November 11-12, 2019 in London, UK

BABE 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment in Pharma, Clinical research, Bioavailability, and Bioequivalence,  which provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come to join us at our event and make it successful by your participation.

PharmaMiddleEast 2019 cordially invites each and every interested and enthusiastic participant from all over the world to take part in the 20th Annual Pharma Middle East Congress, at Istanbul, Turkey during 11-12 of November 2019.

Pharma Middle East 2019 is the most suitable platform to explore ones’ scientific knowledge by sharing trough their presentations and to build a robust network with the eminent people, key decision makers from all-around the academic institutions, Healthcare Institutes, Pharmaceutical, Biotech organizations of the world. The conference aims to build a strong belief that all other health and medical sciences can provide the healthy circumstances by the inter-bonding with the Pharmaceutical studies and sciences and hence the theme Explore the Alliance of Pharmaceutical & Health Sciences. ME Conferences organizes a 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

As the global biopharmaceutical industry continues to grow and evolve, companies are constantly facing pressures to focus on the patient as they improve the quality, efficacy, cost, and compliance of their life-saving products.

The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, cutting-edge technology providers and media partners for North America’s premier biologics event.

Disruption and transformation will continue to be the focus of life science leaders in 2019 and beyond.

Pricing pressures in the US and a growing number of markets globally has already set in motion a search for new and innovative payment models, while the rise of ultra-expensive, potentially curative gene and cell therapies has brought to the fore a heated discussion about the sustainability of industry’s underlying economic and funding model.

The 10th World Orphan Drug Congress is taking place 12th–14th November, 2019 in Barcelona, Spain; and is not an event to be missed.

Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape. The 10th annual event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.

For 2019 we will be expanding the meeting further with a dedicated co-conference on Cell & Gene Therapy and even more dedicated content and tracks than ever before on Clinical/Product Development, Market Access & Pricing, Manufacture, Science & Strategy, Pitch & Partner and Precision Medicine. We will also continue the highly popular Pre-Congress Workshops.

Europe’s #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate new products to market

The 3rd Complement-based Drug Development Summit encapsulates the excitement in the field and provides one platform for every leading complement company to network and learn in an effort to overcome common challenges. Attend this event to:

• Discover the Importance of Gathering Real World Evidence for Development and Launch of New Complement Therapeutics
• Modulate the Alternative Pathway with a Diverse Pipeline of Targets and Modalities
• Hear Clinical Trial Experience to Accelerate your Complement Therapeutics Through the Clinic
• Discover How to Create Translatable Complement Assays
• Improve Translational Biomarker

Last year our focus was on bringing together the complement community to explore the potential of complement inhibition in rare diseases. This year is back better than ever as we explore both the wider potential of complement therapy in rare and common disease indication.

Attend this meeting to gain clear clinical understanding of the potential role of complement in common indications and identify which indication will be the next big opportunity for complement-based therapeutics.

CBI’s Risk-Based Trial Management and Monitoring conference is dedicated to reducing the complexity of implementing an efficient RBM methodology and refining processes while providing real-world strategies to system adoption and process integration.

Digihealth Leaders is an impactful conference, exhibition and insight platform dedicated to furthering the advance of digital health technologies through international funding, finance, investment and deal making.

In the dynamic life science and healthcare sector, LSX connects the people who are tackling the biggest challenges in the industry, and answers the question; where to next and how do we get there?

Join us today!

ACI’s Life Sciences IP Due Diligence Summit is the gathering place for IP and corporate counsel as well as business development executives to learn best practices to map out and conduct a successful and cost-effective due diligence analysis.

We are delighted to announce you about the World Conference on Nursing and Pediatric Healthcare which is going to be held from November 18-19, 2019 at Milan Italy .

The main aim of Nursing Meet 2019 is to bring together Nurses, Registered Nurses Nurse Practitioners, Scientists, Doctors, Professors, research scholars, professionals, leaders, entrepreneurs, innovators, investors, Healthcare Organizers to trade and share their encounters and research results on all perspectives of Nursing and Midwifery

Pharma Integrates is a unique event bringing together key industry leaders across the Pharmaceutical pipeline to share insights and create debate on crucial topics that influence the future of patient outcomes.

Building on a successful 2018, with a presence of more than 90 prestigious speakers and over 350 senior industry executives, the event will once again be at the Leonardo Royal Hotel London Tower Bridge (the new name for Grange Tower Bridge Hotel), London, UK.

The 2019 event will include key speaker slots, panel discussions, workshops and networking sessions to encourage debate and establish connections between representatives from the entire pharma community, including biotechs, SMEs, small to large pharma companies, CROs, CDMOs, consultants, patient groups and academics.

Gavin Conferences cordially invites each and every interested and enthusiastic participant from all over the world to take part in the International Conference on Pharmaceutical Sciences and Drug delivery, at Milan, Italy during 18-19 of November 2019.

Pharma Meet 2019 is the most suitable platform to explore ones’ scientific knowledge by sharing through their presentations and to build a robust network with the eminent people, key decision makers from established universities, Healthcare Institutes, Pharmaceutical, Biotech organizations of the world. The conference aims to make a powerful belief that health and medical sciences will surely create a healthy circumstances by the inter-bonding with the Pharmaceutical studies and sciences and therefore the theme “Optimizing Research reforms of the Pharmaceutical Industry”

Pharma Meet 2019 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics and Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical analysis, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education.

Gavin Conferences cordially invites each and every interested and enthusiastic participant from all over the world to take part in the International Conference on Pharmaceutical Sciences and Drug delivery, at Milan, Italy during 18-19 of November 2019.

Pharma Meet 2019 is the most suitable platform to explore ones’ scientific knowledge by sharing through their presentations and to build a robust network with the eminent people, key decision makers from established universities, Healthcare Institutes, Pharmaceutical, Biotech organizations of the world. The conference aims to make a powerful belief that health and medical sciences will surely create a healthy circumstances by the inter-bonding with the Pharmaceutical studies and sciences and therefore the theme “Optimizing Research reforms of the Pharmaceutical Industry”

Pharma Meet 2019 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics and Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical analysis, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education.

Tropical Diseases 2019 is the only meeting where you can learn about Infectious Diseases from a variety of perspectives, both research-based and clinical. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of Infectious diseases. Global Infections Conferences provides the time to collaborate with industry peers and discover knowledge and resources that can be used to achieve your personal and organizational goals. Infectious diseases meet incorporates, visitor addresses, keynotes, symposiums, workshops, presentations, board talks, poster sessions, and various summits for the all over participants. This meeting will unite many representatives which include worldwide Specialists, Researchers, Analysts, Understudies, Nurses, Exhibitors, Investigators, Microbiologists, Pathologists, Pharmacists, Professors and Industrial Pharmaceuticals and Business delegates everywhere in the globe to connect us Bali in November 2019 for the 2-day Tropical Diseases meet.

 SMi is proud to present the New Ophthalmic Drugs Focus Day  - Novel Drug Delivery Through a Complex Barrier

Introducing the only ophthalmic conference to hold a full day exploring alternatives to intravitreal delivery to the posterior segment of the eye. With the global ophthalmic drug market currently valued at $17,364 million USD, this focus day will asses the growing need for research and development of novel delivery approaches to expand the current ophthalmic delivery methods in today's market.

In conjunction with Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in novel drug delivery through case studies, regulatory outlooks and industry examples to give a comprehensive overview of the Ophthalmic Drug Delivery space.

This focus day offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.

We look forward to welcoming you to the conference in November.

On 18-20 November 2019, the US edition of our NG Supply Chain Summit will bring together senior marketing decision-makers and business leaders from across North America at the fantastic The Ritz-Carlton, Sarasota, Florida, to share their views on how to tackle the biggest challenges in supply chain management today.

Amongst others, the summit will look at key topics such as: how to build an integrated supply chain ecosystem that is intelligent, responsive and meets customer needs in real time; how to deliver true end-to-end visibility, powered by Data, AI & Analytics; and how to improve lead and delivery times, affordably, without interrupting existing processes.

From case studies that lift the lid on operations inside best-in-class organisations, to workshops and collaborative sessions that focus on real challenges and future technology innovations, to one-to-one meetings with industry peers offering practical advice tailored to your specific needs, the summit will provide you with everything you need to implement your key projects more effectively.

We heartily welcome all the participants throughout the globe to participate in the conference titled 12th International Conference on Pharmacoepidemiology and Clinical Research which is scheduled to commence on November 18-19, 2019 at Abu Dhabi, UAE. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacy.

Pharmacoepidemiology 2019 Conference is a multidisciplinary program with far-reaching cooperation with individuals from around the world concentrated on finding out about pharmacology, epidemiology, clinical research and its advances. This stage is your best chance to achieve the biggest get-together of members from Pharmacist and  Clinical Pharmacist people group that is from the scholarly community, clinical scientists, medicinal gatherings, social orders, related affiliations and furthermore from drug specialist, government offices and therapeutic gadget businesses.

Pharmacoepidemiology 2019 describes the activities of the pharmacists done in order to elevate pharmaceutical care and medications for the promotion of health care and disease prevention. Pharmacoepidemiology has a promising history of upgrading the practices through new approaches and innovations. Clinical Pharmacy is more of a patient-centered discipline. The Clinical pharmacy field is not bound to any certain specific areas but has a reach towards other medical fields such as Cardiology, Nephrology, Oncology internal medicine and much more.

The Middle East Pharma Excellence Congress which will be held on 19 – 20 November 2019 in Millennium Airport Hotel Dubai, UAE, will be the premier platform for the pharmaceutical industry and attracts senior local, regional and international leaders from the pharmaceutical industry and government representatives to discuss key issues in the current regulatory environment, key challenges facing the pharmaceutical companies and future opportunities in the region along with a great focus on the revolution of the biopharmaceuticals through a number of interactive presentations, panel discussions and round table discussions. You will have the opportunity to strengthen your relation with the key stakeholders and to discuss the best practices that will help in improving the public health in the region.

6th World Congress on Advanced Clinical Trials and Clinical Research, (Clinical Trials Congress 2019) scheduled to be held during November 19-20, 2019 at Frankfurt, Germany. This Clinical Trials Congress hosts a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions, and Career development programs. It strives to bring all the Researchers, Students and Business people under one roof to share their ideas and conduct collaborated research.

The need for powerful pain medication remains crucial for countless different types of pain conditions. Novel innovations, including abuse-resistant technologies, non-opioid pain drugs, cannabinoid therapeutics, and others in the early stages are making breakthroughs in the pain industry.

While regulations continue to tighten the potential for new drug approvals, it is essential to be aware of all changes in the industry. The Pain Management Summit provides an in-depth evaluation of the current trends in pain therapeutics and technologies, insight on the use of data analytics in prevention and treatment of pain, and an analysis of the future of the pain space.

Conference Series cordially invites participants from all over the world to attend “20th Annual Meet on Pharmaceutical Sciences”, scheduled during November 19-20, 2019 at Bangkok, Thailand, and focused on the theme “Exploring the innovations leading to change the Pharmacy’’.

The conference is a specially organized two days event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, Poster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Understanding key factors behind investigator-initiated research is highly important for successfully answering important medical and scientific questions, which will uncover solutions to unmet therapeutic needs. These solutions can lead to a successful study that can improve patient care and spark new ideas for further disease-related research that will produce improved medicines for people who need them.

The Investigator-Initiated Trials (IIT) Forum covers all aspects of IITs, including the use of performance measures to optimize trials, considerations for running single vs. multicenter trials, best practices for understanding and fulfilling the expectations of industry and sponsors, structured data, analytics and systems management impact on IITs, and ways to foster compliance and strengthen studies for newer sponsor-investigators.

In addition, this forum speaks to the similarities and differences between research collaborations and IITs, including responsibilities; ownership of the research, royalties and publication rights; and, most crucially, when it’s viable and appropriate to support each type of collaboration.

Join us in Philadelphia and return to work armed with the necessary tools and techniques you need to be successful in managing the pursuit of trials that can lead to new and improved therapies and the discovery of new drug indications.

The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.

The dermatology space continues to undergo huge therapeutic innovation and growing competitive pressure, driven by the evolving understanding of the pathophysiology of skin diseases, as well as in the available treatment options for chronic, moderate to severe dermatological conditions and high unmet need that affects the lives of patients worldwide.

The 3rd Annual Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.

Join peers and leaders in this space for an exclusive three-day meeting of comprehensive discussion, sharing of latest advances and pioneering insights, and networking opportunities.

On behalf of Organizing Committee, we take immense pleasure in inviting all the participants across the world to attend 17th International Conference on Clinical Nutrition and Fitness which is to be materialized on November 21-22, 2019 at Singapore. This Nutrition assembly point emphasizes the theme “Exploring novel trends in Nutrition, Health & Fitness".

Clinical Nutrition 2019 is the best opportunity to reach the largest assemblage of participants around the world. The complete session provides a special chance for scientists, researchers, principal investigators, nutritionists, dietitians, fitness experts, healthcare professionals industry as well as biological science experts from all parts of the globe to exchange their research experience, gain new knowledge and establish contacts.

This meeting includes brief keynote introductions, plenary talks, young research forum, symposiums and workshops, exhibitions, poster sessions, B2B meetings and panel discussion on latest research breakthroughs and challenges in clinical nutrition and other nutrition-related fields.

Join us at Clinical Nutrition 2019, the exclusive platform to bring together worldwide distinguished scientists, dietitians, nutritionists and academicians in the field of Nutrition, Public health, Diabetes, Obesity, Nutraceuticals and medicine, Food Technology, Health Sciences, Epidemiologist and more.

We hope to see you in Singapore and look forward to sharing novel ideas and exciting discoveries with you.

Psychiatry Congress 2019 anticipates hundreds of participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations worldwide distinguished academics in the field of neuroscience and neurology, Psychiatrists, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. We are truly honoured to welcome world renowned faculty to Innovate, Educate and invigorate our attendees.

Gavin conferences welcomes participants from all over the world to attend the "International conference on Pharmaceutics, Pharmacognosy and Medicinal Plants"with the theme of " Advances and Challenges in Pharmaceutics and pharmacognosy studies" which is to be held from November 25-26, 2019 at Rome, Italy

Pharmaceutics 2019 aims to explore Pharmaceutics, Drug Delivery Systems and its applications in the development of healthcare products and clinical trails along with pharmacognosy studies of natural drugs. Pharmaceutics and pharmacognosy-2019 sessions cover all aspects of Biopharmaceuticals, Pharmaceutical and Biomedical Analysis, Innovation of Drug Delivery Technologies and Clinical Trials Protocol, Clinical Trials on Different Diseases, Clinical Trial Phases, along with Natural Products of Medicinal Interest, Traditional Medicine, Formulation and Manufacture of Plant Medicines.

Pharmaceutics and pharmacognosy-2019 will create a great platform to researches, Pharmacists and Pharmacy Technicians, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise.

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.

The pharmaceutical R&D and Biopharmaceutics have made tremendous changes in the past few decades in the pharmaceutical industry leading to impressive innovations and dynamic global market growth.


The global biopharmaceuticals market is growing at a phenomenal rate and the market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases, resulting in huge market demand for biopharmaceuticals.


Biopharmaceuticals have reduced the number of deaths due to cancer and HIV/AIDS in the past decade, which has led to an increase in the adoption of biopharmaceuticals in the global market.

CAM  Therapies 2019 is comprised of many interactive scientific sessions on different types of Complementary & Alternative medicine and advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under one roof to explore every single aspect of CAM THERAPIES. CAM Therapies 2019 welcomes the Homeopathists, Acupuncturists, Aroma Therapists, Osteopathists, Naturopathists, and Yoga Instructors, Research scholars, Industrial professionals and Students, Delegates, Chiropractic Physicians, Ayurvedic Physicians, Psychotherapists from medical and healthcare sectors to be a part of CAM and Therapies 2019 Meeting.

The 16th Clinical Performance Metrics & Analytics Summit takes place December 2-3, 2019, in Philadelphia, and this is a one of a kind event you can’t afford to miss!

`More than ever, this year’s summit will bring together sponsors, CROs, and sites to discuss the importance of collecting clinical trial performance metrics/key performance indicators and using analytics to improve your trials performance, collaboration, and real-time monitoring.

The Summit provides a platform for you to share your collecting and reporting strategies while increasing your understanding of the best practices in clinical trial monitoring from industry leaders. After this comprehensive two-day event, you will be able to return to work armed with the necessary tools and techniques you need to effectively measure and improve your clinical trials.

Liver Diseases conference 2019 provides a great platform to grow your connections by gathering eminent people like professors, Researchers, scientists, industrialists, Students and delegates to exchange new ideas and knowledge. This conference is mainly focusing on a wide range of topics and allows participants to discuss about the management of liver diseases and Hepatitis. Liver Diseases conference 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters and video presenters will be judged and awarded during the conference. We encourage a broad participation from all over the world, Conference Series Ltd main motive is to spread the knowledge and exchange the ideas to build a smart and infectious free world.

Pharma Meeting & Expo 2019 focuses on Drug Discovery & Designing, Drug Delivery Research and Technologies, Pharmacovigilance, Pharmaceutics and Pharmacokinetics, Pharma Market Research, Pharmaceutical Manufacturing and many more. Meet your target market with individuals from around the globe concentrated on finding out about Pharma, this is your single best chance to achieve the biggest array of members in our Pharma conference.

Pharma Meeting & Expo 2019 brings Pharmaceutical Industries, Researchers, Healthcare, Business Entrepreneurs, Drug Manufacturers all together under one roof. The two day Expo will gather Directors, CEO’s, Business Development Managers, Chief Scientific Officers, R&D Researchers from Pharmaceutical Industries, Patent Attorneys , Business Development Managers, Bio instruments Professionals, Bio-informatics Professionals, Research Institutes Members, Ph.D. Scholars,  Professor & Associate Professor, Manufacturing Companies at a common platform and permit  the exhibitors to enhance their business and networking.

The 9th International Conference on Cardiovascular Diseases & Therapeutics is scheduled during December 02-03, 2019 at Berlin, Germany which focuses on the theme of “Novel research approaches and disruptive MedTech inventions modernizing cardiovascular care’’. This Cardiovascular Disease  conference is designed to provide diverse and current education that will keep medical professionals alongside of the issues affecting the diagnThe 9th International Conference on Cardiovascular Diseases & Therapeutics is scheduled during December 02-03, 2019 at Berlin, Germany which focuses on the theme of “Novel research approaches and disruptive MedTech inventions modernizing cardiovascular care’’.

This Cardiovascular Disease  conference is designed to provide diverse and current education that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Cardiac Disorders and prevention. The key strategic objective of this conference is to conduct communal interdisciplinary research in state of the methodologies and technologies within its areas of expertise. Renowned speakers all over the globe are welcomed to talk about  their researches and  developments, and also discuss about the latest updates  and new  techniques for the  treatment  and surgery  involved  in Cardiology are hallmarks of this conference.osis, treatment of Cardiac Disorders and prevention. The key strategic objective of this conference is to conduct communal interdisciplinary research in state of the methodologies and technologies within its areas of expertise. Renowned speakers all over the globe are welcomed to talk about  their researches and  developments, and also discuss about the latest updates  and new  techniques for the  treatment  and surgery  involved  in Cardiology are hallmarks of this conference.

In order to stay current with technological innovations, marketers utilize programmatic and advanced ad-tech strategies to most effectively reach their target customers. These programmatic technologies enhance a company’s leverage, decrease its costs, and prove to be an overall effective method of marketing. Due to immense privacy regulations and a lack of recognition in utilizing these technologies, the healthcare industry is lagging behind. It is essential to create both awareness and application of programmatic technologies within the healthcare space.

The Programmatic Marketing Summit for Healthcare and Life Sciences is designed for advertising, marketing, digital, and branding professionals from health systems, pharmaceutical companies, insurance providers, drug manufacturers, pharmacies, publishers, and agencies to gather and discuss common challenges in the implementation of digital innovations.

Join us for this two-day, educational event to learn top strategies for enhancing your audience engagement and virtual advertising and network with leading marketers, industry professionals, and decision-makers to collaborate on joint ventures.

Scholars International is proud to announce the Scholars International Conference on Pharmaceutics and Drug Delivery Research, which is to be held during December 02-03, 2019 at Madrid, Spain.

The Conference will also have a space for companies and/or institutions to present their services, products, innovations and research results. Pharmaceutics 2019 involves the tracks like Drug Delivery Technologies, Novel Drug Delivery Systems, Routes of Drug Administration, Pharmaceutical Nanotechnology, Nucleic Acid Based Drug Delivery, Smart Drug Delivery Systems, Nano Pharmaceutics and Advanced Drug Delivery, Bio therapeutics as Novel Technique in Drug Delivery, Drug Delivery and Device Development, Major Challenges in Drug Delivery, Peptide and Protein Drug Delivery, Drug Delivery Equipment and Machinery, Business Opportunities in Drug Delivery, Vaccine Based Drug Delivery Technology, Drug Delivery and Device Development.

The two-day meeting is going to be an event to look forward to for its enlightening symposiums & workshops from established experts of the fi eld, exceptional keynote sessions directed by the best in the business. It will also prove to be a brilliant open door for the representatives from Universities and Institutes to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach. Interested individuals can confirm their participation by registering for the conference along with their colleagues.

Virtual clinical trials bring the clinical trial experience to the patient. Through these VCTs, companies are expected to reduce trial costs and increase patient enrollment and participation. There are new technologies that make these trials easier to conduct and with the patient demand for more flexibility in their participation, this new way of doing business will only continue to expand for the industry.

In this ExL Forum, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

With the goal of a successful virtual trial in mind, we will discuss the team needed to ensure consistency in a newly developed and comprehensive VCT program. This will require the building of an optimal and collaborative network and the utilization of external partnerships, aside from technology vendors and service providers, this means healthcare providers and other partners that will only continue to advance the patient experience. Join us as we navigate this new way of conducting clinical trials!

APTEKA is a priority exhibition in Russia that brings together all pharmaceutical industry participants: manufacturers and distributors of medicines and medical products, representatives of pharmacies and pharmacy chains, medical practitioners, new drug developers, and healthcare authorities.

APTEKA exhibition is part of the Russian Healthcare Week International Scientific and Practical Forum, which includes a series of exhibition and congress events of medical and pharmaceutical subjects, assembling the medical community from all over Russia.

The MENA pharmaceutical market has recorded significant growth in the past few years, as a result of increased spending power, growth of aging population, and lifestyle associated diseases, hence, many governments in the region, including KSA, have started encouraging more investments in the local pharmaceutical manufacturing, either through building new pharmaceutical industrial areas, or through attracting more foreign direct investment. Some of the biggest European and American Pharmaceutical companies have ongoing projects establishing new pharmaceutical plants in the MENA region, including Saudi Arabia, which is expected to be the leading pharma manufacturing hub in the region by 2025 - according to the country’s 2030 vision.

That’s why the MENA Pharmaceutical Manufacturing Congress and Exhibition, will set a unique platform by gathering the pioneers from the local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulatory aairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing along with the API manufacturers
The congress will feature a spacious exhibition area showcasing the latest machineries and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, regional manufacturers, contract manufacturers and more.
The MENA Pharmaceutical Manufacturing Congress and Exhibition, is your opportunity to present your technologies and solutions to gain visibility, generate leads, and improve your business performance.

ManuPharmais the World’s most senior advanced pharma manufacturing conference. Tackling both small molecule and biologics manufacturing challenges at a strategic level, it allows senior pharma manufacturing decision makers to meet, benchmark, and learn from real examples - delivered by the best in the industry.

ManuPharma2019 will bring together 180+ Heads of Manufacturing, Heads of Tech Ops, Directors of IT (Manufacturing) and Site Leads and 50+ manufacturing thought leading speakers over 2 value packed days.

Download the agenda to discover how pharma are driving projects in Industry 4.0 & Smart Manufacturing; Digitalisation; Innovative Tech & Operations Transformation and Continuous Manufacturing.

As a proud partner of the event, we are pleased to offer you an exclusive 15% discount off the current price to attend, using our code:PHARMATECH19

Book your place online here: http://bit.ly/2JvO1ai

International Natural Health & Nutrition Expo (NHNE), as Asia’s largest expo on natural health and nutrition products, helps global manufacturers of health food and nutrition to promote their brands and expand business channels in China. With over 100,000 distributors and retailers, it’s been the best platform for participants to search for new products and chase golden opportunities for entering Chinese market and expanding their business map in China.

India Cold Chain Show 2019 is the most renowned and dynamic business-to-business show catering to India’s Cold Chain industry. With a success story of five years, the show has enjoyed being the sole trading voice for cold storage infrastructure, refrigeration, reefer transport, temperature controlling, IT solutions and data storage solutions. Cold storages and supply chain companies have been the permanent target audience for ICCS as they are the biggest buyers of equipment and technology.

India Cold Chain Show extends a unique platform to meet and interact both Indian and international brands. It brings together manufacturers and suppliers to meet end-users, distributors, consultants and other key industry players from across the globe. The show allows visitors and exhibitors to build new and strengthen existing contacts, learn new industry trends, technologies and upgrade their products and services.

It is our great pleasure to invite you to take part in the major event 32nd World Pediatrics Conference which is mainly focusing on how To Promote Excellence in Pediatrics Research and Child Health which was scheduled on 04-05 December 2019 in Barcelona, Spain.

The main objective of the conference is to bring together pediatricians, neonatologists, experts in child development and other specialists to exchange their ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations.

Back even more scientifically stringent, the 2nd Clinically Validated DTx Summit 2019 is dedicated to the development, commercialization and integration of evidence-driven digital therapeutics. Uniting pharma, DTx companies and healthcare institutions, this summit is solely focused on the actionable uses of digital therapeutics that are delivering better patient outcomes.

Tackling a multitude of disease areas and therapeutic modalities, this summit will link R&D innovation to the tangible sustainment of the DTx industry.  Hosting clinical and medical data to move beyond the future-focussed hype into the current real world application of DTx, this summit integrates advocacy for the progression of collaboration, partnering and evolution of business models to the benefit these therapeutics can bring to patients worldwide.

The 8th annual PREDiCT: Tumour Models London Summit will return this December (4-6) with a fresh speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts, including Merck, MedImmune, Sanofi, Institut Gustave Roussy, Basilea Pharmaceutica and more for practical insights.

SMi are pleased to announce the launch of  the Respiratory  Drug Delivery  conference as part of the newly branded Asthma and COPD series, which will be held in London on the 5th-6th December 2019.

With the rising prevalence of respiratory diseases such as Asthma, cystic fibrosis and COPD, this group of diseases are now amongst the leading cause death, affecting over 500 million adults and children worldwide. Lung cancer now accounts for over 50% of all respiratory disease related deaths in Europe, yet little work is being done to reduce this high mortality rate.

Opportunities for drug development has effectively resulted in the global pulmonary and respiratory drug delivery market expecting to reach 64 billion USD (6.7% CAGR) by 2025. However, the unmet medical needs of respiratory disease sufferers remain.

Join us this year as SMi aim to bring together clinical researchers, respiratory drug manufacturers and solution providers to discuss the current research and developments in providing appropriate long-term treatments that adhere to patient’s needs, analyzing the success of digital medical devices and connective health technology in aiding the diagnosis of severe asthma and COPD. This year will also investigate the developing issues surrounding pulmonary and nasal combination product design.

Conference Series LLC Ltd is delighted to invite you to attend the 2nd World Congress on Drug Discovery & Drug Design, one of its remarkable Pharmaceutical conferences, to be held during December 5-6, 2019  in Dubai  emphasizing on recent areas of more optimized research techniques like rational and computer aided drug designing for the Discovery, Designing and Development of new drugs than by traditional hit and trial method. This Drug Discovery 2019 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Conference Series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conferences organize worldwide.

Biomarkers Congress 2019 welcomes all the participants from all across the globe to attend the “ 2nd Annual Biomarkers Congress” which is slated on December 06-07, 2019 at Berlin, Germany with the theme ''Biomarkers: a new era of detection and clinical exploration''. The key vital goal of Meetings International is to impart science and medicinal research amongst the academic/scholarly community, and industry. Biomarkers in the hands of the clinical inspector offers a powerful and effective approach in understanding the opportunity of diseases with distinct applications in analytic epidemiology, biomarkers and clinical research in disease prevention, detection and disease management. Biomarkers have the possible supplementary to find each susceptible to particular diseases. This conference is a platform that brings and shares collective ideas, knowledge and research survey in biomarkers study. In the recent years, the statistics about cancer biomarkers has expanded a massive potential in upgrading the administration of cancer patients by boosting the precision of diagnosis and efficiency in the treatment. Recent technological improvement has a license that the investigation of many viable biomarkers recommende interest in advancing the new biomarkers. All such developments can be exhibited in this biomarker congress.

Clinical Microbiology is the most fundamental branch in the field of Medical Science that focus on the cause, diagnosis, treatment, and prevention of infectious diseases and different clinical applications of some beneficial microbes for the improvement of health in today’s world.

LexisConferences Conferences feels immense pleasure to invite you to Clinical Microbiology Conference 2019 that provides a platform with its well organized scientific program for the audience which includes Keynote session, Panel discussions, Plenary talks, Poster sessions, Exhibitions, Workshops, etc. The gathering involves the expertise in the field of Microbiology, Virology, Bacteriology, Parasitology, Mycology, Pathology, Pharmacy, Epidemiology, Health-Care and all young researchers and enthusiasts in the related fields.

ME Conferences merrily welcomes you to attend “2nd International Conference on Pharmacology and Toxicology” during December 09-10, 2019, at Dubai, UAE with a theme of Widening the possibilities in Pharmacology and Toxicology. ME conferences is an Open Access Initiative is committed to making genuine and reliable contributions to the scientific community.

On behalf of the organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Pharmacology and Toxicology. World Pharmacology 2019 conference is scheduled during December 09-10, 2019, at Dubai, UAE. This conference aim is to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe. The World Pharmacology 2019 organizing committee is confident that participants will get benefits from this high-value scientific program. We welcome all the researchers/ academicians join us at Dubai, UAE.

Pharmacology is integrative of fields like biochemistry, toxicology, genetic engineering, molecular engineering and its advancement using nanotechnology. Pharma includes health care contribution to drug development and discussed research and innovative works in the pharmacy field. During this conference, the international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of pharmacology and toxicology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. In all its ways World Pharmacology 2019 creates an opportunity to make partnership deals which will turn into a cent percent success meet.

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders

This December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will be converging at the first industry led Glioblastoma Drug Development Summit under a common goal of accelerating the practical discovery, translation and clinical development of safe, effective and deliverable therapies to treat glioblastoma.

This meeting provides a truly unique platform for discussions aimed specifically at helping you not only successfully translate drug candidates into human clinical trials, but optimize the clinical development itself to avoid more clinical failures.

Gain exclusive insights into tackling specific and applied drug development challenges limiting effective therapies. This includes tumor heterogeneity, redundant pathway signalling, the immunosuppressive tumor environment and penetration through the blood-brain barrier.

With an increasing number of failed phase II trials and a very poor standard of care, there has never been a more important time to attend the Glioblastoma Drug Development Summit and join those striving to advance safe and effective therapeutic breakthroughs to patients in need.

The Drug Delivery to the Lungs (DDL) Conference provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

DDL2019 will have five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science.  Alongside the lecture programme is a large industry exhibition and inhalation science poster exhibition.

The investor conference that drives the future of drug development. More than $330 billion in capital represented.

SMi is proud to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices Conference in London on 15th and 16th January 2020.

As Europe’s leading PFS conference and given the key factors driving the market, we will assess innovations in design controls and applications, enhancement of human factors and optimizing formulation and containment.

The rapid expansion of the PFS market and the regulatory environment are more important than ever, this year’s programme will look at the EU MDR, Article 117, ISO change management standard as well as insights into the MDR post-market safety report, providing a holistic review of the Pre-Filled Syringes industry.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

We look forward to welcoming you to the conference in January.

This is our most sought-after event and will be sold out soon.

The age of digital medicine is here!

McKinsey estimates that big data and machine learning could generate up to $100bn in pharma and medicine annually. There has never been a more pressing need for pharma to transition to digital as existing technologies are being disrupted by Artificial Intelligence, Machine Learning, Virtual Reality, Internet of Things and Blockchain, while newer categories such as Prescription Digital Therapeutics begin to offer truly disruptive benefits.
 

As new technologies are being incorporated into pharma it is crucial, we reflect on trends in cutting-edge innovation and explore new tech-enabled opportunities to cut costs and save time.

Partnerships are at the heart of digital transformation. Innovative approaches to partnerships are leading the way towards more effective data collection, faster R&D, seamless clinical trials and above all, more patient-centric medicine.

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.
 

Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

Global Pharmaceutica 2020 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

The 12th REMS Summit convenes pharma, FDA, healthcare providers, and patient advocates to delve into specific topics to enhance the understanding of when REMS are necessary the elements that need to be included in the REMS needed for their product, as well as details required for submission. Our adept speaking faculty will arm you with proven strategies to facilitate benefit-risk counseling, optimize REMS operations through streamlined health system integration, leverage interoperable technologies for consistent communication, and increase patient safety through cross-functional collaboration.

Four years in the drug development world isn’t long, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA and maturing technology; both pharma and biotech are starting to adopt continuous manufacturing (CM) in a commercial setting.

Over the last 12 months we have seen major milestones in continuous manufacturing globally – PROSPECT project in the UK, GSK’s announcement of CM facilities in Singapore, Merck has filed an NDA under CM approach, Bill & Melinda Gates Foundation granted $14.3m to Univercells to deploy CM for measles and rubella vaccine continuous manufacturing.

At the 4th Annual CCP Summit we will continue to explore scientific and technology advancements that can help eliminate bottlenecks, and more importantly, will address the quality, upfront investment and business rationale behind the ‘switch’.

Join us at the 2020 National Manufacturing Conference & Exhibition on the 29 – 30 of January to hear from an impressive line-up of manufacturing leaders, academics and government agencies who will engage in a stimulating blend of key note addresses and debates.

SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th of February 2020. As the only  B2B parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The size of the EU market in pharmaceutical distribution is around €5bn, and the UK accounts for 22.7% of this figure. The sector has an annual import value of around £1bn, while the annual export figure approximates £600m.

The 2020 event will hold a particular place of significance on shortages of medicines, current and ongoing challenges posed by Parallel Trading, potential implications of Brexit and IP exhaustion rights.

Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2020. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

The growing potential of blockchain applications needs no introduction these days. It has the potential to revolutionise the healthcare industry, and to be a part of this revolution it is crucial for you to first understand the nature of blockchain technology.

At Blockchain in Healthcare Congress, you will hear experts from international healthcare organisations, academic and companies at the leading edge of technological solutions. They will help you to distinguish the hype from the reality and then to hear real-world case studies of how blockchain can be and is being, applied to healthcare systems.

The meeting is co-located with the 2nd Global Cyber Security in Healthcare & Pharma Summit and your pass will also give you full access to this meeting. In addition, you have the option to attend the H-ISAC (Health Information Sharing and Analysis Center) London Workshop: Healthcare Cybersecurity

The importance of cybersecurity and the growing potential of blockchain applications need no introduction these days.

Anybody with responsibility for security, IT, e-health, medical devices and innovation in the health sector must be prepared to meet the challenges and opportunities presented by both of these elements.

At the Global Cyber Security in Healthcare and Pharma Summit, you will hear experts from international healthcare organisations, academic and companies at the leading edge of technological solutions.

The meeting is co-located with the 2nd Blockchain in Health Congress and your pass will also give you full access to this meeting.

This two-day meeting has been purposely designed to facilitate collaboration and attract attendance from multiple stakeholders including KOL, investigators, academia, pharma, providers and regulators. The conference will examine the latest research and development in pathogenesis, diagnosis and treatment of the disease. As well as exceptional speaker presentations the meeting features 10 roundtable discussions. Each is led by an expert to provide you with a unique opportunity to debate the issues in areas such as the regulatory challenges for FDA approval, NASH and Diabetes and Preclinical models, to name just four.

Gynecology 2020 destine to endeavor leading-edge memoranda of eminent keynote speakers, universal personalities, special sessions and poster presentations attracting experts in Gynecology and Obstetrics field. This conference has been designed to bring out the ravishing ideas where it takes up a Gynecology field to the next set of standards. inclusive of enlightening presentations and discussions, we have planned to offer a chance to organize a workshop.  

The core objective of this event is to empower and bring about maximum exposure to our attendees, so we make sure that this event is a blend which covers professionals such as Gynecologist, obstetricians, paediatrician, oncologist, physicians, medical assistants, midwives, nursing assistants, Health Care Administrator, nutritionist, therapists, medical secretaries, women health care professionals and students with wide knowledge, choices and recommendations that will support them; make them more informed about healthcare and make better decisions in managing reproductive health of women.

Gynecology 2020 is setting its scaffold in France to present  and bring about the researchers of  Gynecology and Women Health under one crown by providing opportunities to Young Researchers, to meet and socialize with the experts to establish global network.

We hope that you will join us in the Paris and make up your precious time to share your experience and research work  to lead the future in Gynecology and obstetrics field.

The 15th Annual Biomarkers Congress is part of the Biomarkers Series UK, new for 2020 also encompassing the Genomic Markers Congress and a Pre-Event Focus Day featuring Deep-Dive Therapeutic Focus Sessions and End-User Workshops

SMi Group announces the 11th Annual RNA Therapeutics Conference in London on February 19th - 20th 2020.

The field of RNA therapeutics is rapidly expanding, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

The global antisense and RNA therapeutics market size is expected to expand at a compound annual growth rate (CAGR) of 8.6% between 2019 and 2025, when it is projected to reach $1.81 billion. RNA-based drugs, including short interfering RNAs and antisense oligonucleotides, are particularly promising examples of this newer class of biologics. For over two decades, researchers have been trying to overcome major challenges for utilizing such RNAs in a therapeutic context, including intracellular delivery, stability, and immune response activation. Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field.

This year, we will maintain our focus on the latest research and developments on delivery system technologies that aim to tackle more difficult targets within the human body. This overarching topic warrants high focus and therefore we will, for the first time in the series, introduce a focus day on Oligonucletide Delivery Systems. Our main conference will focus on current developments in the area of mRNA therapeutics in immunotherapy and vaccination. We will also cover a fair bit of regulation, such as continuing upon patenting novel products, release of new 2020 regulations in the clinical trials arena, as well as ensuring compliance. Finally, a significant section that tackles novel and emerging therapies as well as the latest research findings from academia will also be present in this year’s agenda.

Join us in February 2020, as SMi’s RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.

Cell Culture in an important tool for research and development within the life science industry. OThe global 3D Cell Culture Market market is valued at USD 1069.28 Million and is expected to grow with a CAGR of 25.31% over the forecast period. Researchers globally are realizing the potential of 3D cell culture for various applications, including models for personalized medicine, complex and multi-cell type models, translation and clinical and industrial applications.

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

SMi’s 3D Cell Culture conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

2nd European Biotechnology Congress is the world’s leading conference for all professionals to gather and contribute their research. Biotechnology Congress 2020 offers over 10 sessions from different areas in the field of Biotechnology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations.
 

2nd European Biotechnology Conferences which is going to be held in global city February 19-20, 2020 during Paris, France will address fast growing technologies in the field of biotechnology with significant opportunities for Biotechnology Conferences.  2nd European Biotechnology Conferences will bring together practitioners, researchers, clinicians in a universal forum, enabling the exchange of novel advancement in the field of Biotechnology in both science and practice. Biotechnology Congress 2020 is the best place to enhance networking and would provide opportunity to interact with world’s leading scientists and researchers.

The Only Event In Asia Providing The Latest Science, Technology And Partners To Accelerate Antibody & Protein Therapies, Adcs, Bispecifics And Immuno-oncology.
 

World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track your next-generation therapeutics towards commercial success

Conferenceseries LLC Ltd is very excited to welcome participants to Rome, Italy at Pharmaceutical Nanotechnology and Nanomedicine scheduled during February 24-25, 2020.

Nano Pharmaceuticals 2020 will illustrate innovative research ideas on Nano medicine & Nanotechnology, Pharmaceutical Technology, Drug Delivery, Medical Devices for Drug Delivery, Biotechnology ,Nanorobots and Formulation Technology, This conference presents a fantastic line-up for many international experts such as Professors and Ph.D Scholars from academia, Clinicians, R&D Scientists, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors and Suppliers of Drug Delivery Technologies, Business Entrepreneurs, Health professionals & Pharmacist, Quality control specialist. It provides interdisciplinary platform to present and discuss the most recent innovations, trends as well as practical challenges encountered and solutions adopted in the fields Nanomedicine & Nanotechnology.

The global Nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to market research report Nanomedicine Market 2016-2020.

Welcome to the “20th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry” Conference at Dubai, UAE during February 24-25, 2020.

The Conference will carry out upon the theme “New Challenges in Pharma Industries and Growth of Pharmaceutical Research”

DUPHAT is the premier Pharmaceutical and Technology event in the Middle East launched in 1995 by INDEX® Conferences and Exhibitions Org. Est., a member of INDEX Holding in collaboration with the government through the Dubai Health Authority with the aim to provide a high-quality conference and a wide-ranging exhibition.

Neonatology 2020 features outstanding and internationally renowned neonatologists, perinatology experts, paediatricians, academicians and researchers. The representations include premier medical universities, hospitals and healthcare/pharma industries from all around the globe. The topics covered at the conference would range a spectrum of Neonatology, Perinatology and Pediatrics. Attendees of the conference would be delighted to witness various interactive workshops, keynote lectures, speaker talks, and poster presentations and most significantly the exhibitions held by the top healthcare and pharma industries. The conference also has Young Research Forum, where the budding researchers are encouraged to give oral presentations.

Join 5,000 key suppliers and buyers at CPhI South East Asia - the region's leading pharma solutions event.

Our event offers you the chance to do business in a booming and expanding market, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics.

The exhibition hosts a wide range of networking opportunities to grow your business including dedicated Forums, Product Showcases, Technical Seminars and much more.

After a successful conference of Pharmaceutica 2019, Pharma Conferences team cordially invites participants from all over the world to attend "21st International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems"  (Pharmaceutica 2020) slated on March 11-12, 2020 at Rome, Italy. This Pharmaceutics Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Novel drug delivery systems Conference is one of the well-established conference among Pharmaceutical Conferences organized by Conference Series llc Ltd

Pharmaceutica 2020 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London on 16th-17th March, 2020.

AI-empowered machine learning technologies hold the potential of reducing drug discovery associated costs by US$ 70 billion in the upcoming 10 years. With an estimated +39% CAGR, AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.

The presence of AI in drug discovery is tangible with the majority of drug discovery scientist already working with AI-enabled platforms using machine learning and deep learning, neural networks and natural language processing. However, there is a long journey ahead of optimizing AI-human connections and understanding the full potential of AI-enabled tools and platforms.

Those who work in the field know that there is no AI revolution without tackling the field’s number one challenge: DATA. It is crucial now more than ever to come together and discuss strategies to achieve data revolution for further advancing R&D.

Join us at SMi’s inaugural AI in Drug Discovery 2020 Conference and explore the latest AI-enabled approaches for lead compound screening, multi parameter optimization, disease modelling, drug synthesis and design.

Gathering 20,000+ pharma professionals from 65+ countries worldwide, CPhI Japan is the ideal business platform for international pharma professionals to join in order to grow business in the rapidly changing Japanese pharmaceutical market. Hosting 550+ exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery - CPhI Japan and co-located events is your ultimate one-stop-shop to find the latest Japanese pharma solutions.

Taking place on 17 – 18 March 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement.

Join 120+ senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation, co-create value with business partners and unlock more innovation from suppliers. To learn more aboutProcureCon Pharma, download the agenda.

Take away answers to all of your top challenges:

•    Deliver on and communicate value-added procurement activities to increase credibility as a business partner
•    Identify and adopt eProcurement technologies to modernize procurement
•    Move from buyers and sellers to long-term strategic partners through SRM and Supplier-Led Innovation

For more information including the incredible speaker line-up, download the agenda here:  http://bit.ly/2mfBJuy

Oxford Global is proud to present the highly anticipated 3rd Annual Formulation & Drug Delivery USA Congress to be held in San Diego, USA. The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions

Over 300 delegates representing leading pharmaceutical organisations, biotech companies internationally renowned research & academic institutions will be present

Over 55 case studies and presentations focused on exploring challenges and solutions in formulation and drug delivery of small and large molecules. This includes the latest strategies for optimizing pharmaceutical formulations, new drug delivery systems including nano & RNA delivery, Quality by Design for continuous manufacturing and processing, and the bioanalysis, characterisation and stabilisation of drug products

Join more than 500 digital pharma marketers, technologists, and digital agencies at ePharma 2018 to discuss the ongoing digital evolution of marketing practices in pharma and biotech and the continual digitization of the patient and HCP journeys.

ePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies, out-of-industry perspectives, and leading-edge technology, providing attendees with strategies and tactics to grow as leaders, embrace disruption, and seize innovation.

Injectable drug delivery is considered one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, as well as the improved patient experience. The global injectable drug delivery market continues to grow and technology is advancing. This, coupled with the ever-changing regulatory requirements, means that it is imperative for companies to stay abreast of the latest developments and challenges within the industry in order to remain compliant, as well as gaining a competitive edge.

This seminar has been designed for all those working in the industry to discover the next generation of injectable drugs and devices and get an update on the latest trends, technologies and applications. Attending this event will provide a great opportunity to network with industry leaders, as well as like-minded professionals, to share common experience and best practice.

ConferenceSeries Ltd is a renowned organization that organizes highly notable Pharmaceutical conferences throughout the globe. Currently we are bringing forth “3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry” (Pharma Research 2019) scheduled to be held during March 23-24, 2020 at Barcelona, Spain. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Research and Innovations in Pharma Industry.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The importance of the pharmaceutical industry in the modern-day society cannot be overstressed especially as there are new diseases springing up from different areas, strengthening the importance of adequate drug research and development activities. However, with the growth of the industry, comes the increase in fake drugs. In recent times, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO), about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters. The upcoming regulations are meant to secure the pharmaceutical supply chain and comes as a result of rising drug related criminal activities and supply chain inefficiencies.

 
To protect your brand and build a genuine future, Corvus Global Events invites you to 3rd Annual Pharma Security World 2020 – Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
 

It gives us a great pleasure to welcoming you to the 3rd Annual Pharma Security World 2020 - Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference.

It is a big pleasure to invite you to the 2020 EAHP Congress, hosted by the beautiful city of Gothenburg. Gothenburg, or Göteborg in Swedish, is Sweden's second most populated city and capital of Götaland. It might be colder by climate, but it has a warm and charming atmosphere, friendly and open citizens. A city with an intense history, famous for Scandinavia's largest harbour, blue trams and as a home of the best known Swedish automotive industry brand.

For hospital pharmacists, another chapter of the profession's history will be written in 2020, when Gothenburg hosts the 25th Congress of the European Association of Hospital Pharmacists (EAHP). "Hospital Pharmacy 5.0 – the future of patient care", as the Congress' main headline sounds, hints at an exciting glimpse to the future of our profession. Indeed, the Congress participants will have an excellent opportunity to learn about and share their experience with the latest advances in technologies that will shape the way how pharmaceutical care in hospitals will be delivered in the upcoming decades. Artificial intelligence, mHealth, 3D printing, personalised medicine, all of these will influence our work towards the optimal outcomes for our patients and have the potential to change our workflows profoundly. The Congress will also cover the ongoing challenges in our work, like tackling antimicrobial resistance, delivering seamless care, raising the quality of hospital pharmacy compounding, advances in clinical pharmacy or the role of hospital pharmacists in the multidisciplinary teams in hospital and on the interface with community or outpatient settings, just to name a few. We know that you expect high-quality scientific content from the EAHP Congress, and the EAHP works hard on delivering the programme that will meet your expectations and needs.

Nevertheless, the EAHP Congress is not just a scientific event – it is also an opportunity to meet colleagues from different countries in Europe and around the globe. While we may encounter many differences in the healthcare systems, human and economic resources available in our hospital pharmacies, the patients' needs are universal, and we can inspire each other. So do not miss an opportunity to meet old and new friends in Gothenburg, to bring home new knowledge as well as skills and to use them for your patients. See you in Gothenburg!

LexisConferences is delighted to invite all to the upcoming World Biosimilars & Biologics Summit 2019 which is going to be held on March 27-28, 2020 at Newyork, USA.

Biosimilars Summit 2020 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as Researchers, Analysts, Pharmacists, Pharmacovigilants,  Regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Young Investigators Forum, Special Sessions, Panel Discussions, Exhibitions, Poster Presentations, Workshop and Symposiums.

Biosimilars Summit 2020 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars, biologics, biopharmaceuticals and more. This conference will provide all our participants Business 2 Business sessions, where they will be able to reach out and make a mark for themselves globally.

The Global biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 4.49 Billion in 2017, at a CAGR of 31.7%. By far European Countries dominate the market owing to the favorable government regulations in this region representing 80% of global spending followed by USA which approximately covers around 50% global biologics market and coming to Asia it is expected that in the next 5 years global pharmaceutical spending will rise upto 43% from a roughly 38%.

For 24 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.

Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. Today, we need a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line.

To affect this change, 2000+ pharma-decision makers (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) will join heathcare innovators on their yearly journey to the 18th eyeforpharma Barcelona Conference.  Let's usher in a new era of collaboration and truly achieve value-based care.

analytica is the International Trade Fair for Laboratory Technology, Analysis and Biotechnology. Our unique exhibition profile combines all the aspects of modern analysis employed in industry and research. Gain a complete overview of the market by attending the analytica conference and our practice-oriented supporting program. Join us out in front.

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. Apart from having an end to end visibility and traceability within the supply chain, an effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market is estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures.
 

Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate.

Gavin Conferences invites participants from all over the world to attend “International Summit on Pharmacology and Drug design”. Pharmacology 2020 is a two-day congress going to be held at Hong Kong from April 06-07, 2020 and is open to attendees, academics and non-academic audiences.

The Theme of the congress is " Scientific breakthroughs and discoveries in drug action".

The two-day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.

Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutics and Drug Therapeutics”. Pharma 2020 is a two-day congress going to be held at Hong Kong from April 06-07, 2020 and is open to attendees, academics and non-academic audiences.

The Theme of the congress is " Advancements in Drug Development & Research".

The two-day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.

Advanced Chromatography 2020  organizing committee invites analytical expertise, researchers, professors, scientific communities, delegates, students, business professionals and executives to attend the “International Conference & Expo on Advances in Chromatography & HPLC Techniques” which is to be held during April 20-21,2020 Berlin, Germany.

In the light of this theme, the conferenceseries aims to provide a forum for international researchers from various areas of analytical chemistry, pharmacy, pharmacology, bioinformatics and other life science groups by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects regarding advances in HPLC and Chromatography techniques.

The conference provides a platform to detail the research works of analytical expertise from various scientific backgrounds and the same can be perceived by young researchers and students. The conference mainly aims to promulgate knowledge on chromatography and unveil the advances in HPLC techniques. Both Life Sciences and Chemical Sciences need analytical techniques in course of research work and therefore Advanced Chromatography 2020 would be a perfect venue to share and develop knowledge on key analytical tools.

Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference to Boston on April 21-23, 2020, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.
 

Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.
 

Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
 

Where the top minds in pharma supply chain, logistics, distribution, planning, IT, quality and sourcing meet to share practical insights on how to achieve digitalisation, end-to-end visibility, customer-first strategies, and much more!

With over 950+ pharma supply chain leaders exclusively in one place at one time, this is THE meeting place to benchmark your business with the best and shape the future of your industry.

Drug Delivery 2020 promises to revolutionize our lives through the approaches of discussion & research work about the new medicine, various dosage form, their formulation, route of administration, Efficacy, interaction, mechanism of action within body & their pharmacological, therapeutic effect & some post marketed study like adverse drug effect, patient acceptance. The conference organizers aim is to gather the doctors, professors, researchers, students, other faculty members, academicians, pharmacists, experts and scientists from the pharmaceutical field and Novel drug delivery community to create an opportunity of global exchange of information on technological advances, new scientific innovations, patient comfort, therapeutic effect of drug and the effectiveness of regulatory programs, application, future prospects, importance of the novel drug delivery system.

The pharmaceutics and drug delivery sectors are rapidly transforming into a new level with the development of new technologies and innovative therapeutics. It is further forecast to have a tremendous growth and major changes in upcoming years. Pharmaceutics and Advanced Drug Delivery Systems provides a wonderful platform for interconnecting all these aspects to exchange technological & scientific knowledge to enhance the skills and awareness of scientific community for the betterment and well-being of society.

Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, alternative scaffolds, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

• Biologics Manufacturing, CMC & Continuous Biomanufacturing
• Cell & Gene Therapy Manufacturing: Insights, Key Strategies & Novel Approaches
• Upstream Processing, Digitalisation, Smart Factories, Tools & Technologies
• Downstream Bioprocessing: Recent Technological Advancements and Latest Trends

Pharma industry leaders gather annually at CPhI North America to discuss pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs as well as advancements in bio-manufacturing.

After the successful completion of the 2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry, LexisConferences  with great pride and honour announcing its 3rd International Conference  on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Vancouver, Canada during May 8-9, 2020. This Conference is mainly focused on the THEME: “Collaboration of advanced Pharmaceutical Analytical Techniques”.

This time Pharmaceutical Analysis 2020 want to bring huge number of participants from around the globe focused on learning about Pharmaceutical Analytical Techniques and its advances. This is your best opportunity to reach the largest assemblage of participants from Pharma research community that is from academia, Analytical entities, Laboratory Technical Departments, regulatory agencies, R&D departments, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Pharmaceutical Analysis 2020 will discuss various disciplines involved in the field of Pharmaceutical Analysis & Analytical Chemistry procedures and Validation it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of Analytical Techniques. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new Pharma analytical research developments, and receive name recognition at this 2-days event by sharing and Exploring of Knowledge in Present trending Research field of yours. You can also find out how innovators are minimizing the gap between product development and adoption, conduct demonstrations, distribute information, meet with current Scientists, and make a blazon with a new research, in Pharmaceutical Analysis and its Techniques.

This Conference serves as a Stage for the international experts in the area of pharmaceutical analysis and analytical chemistry throughout the world. We cordially invite all the eminent Scientists, researchers, students, industry representatives, Business entrepreneurs & academicians, working in these exciting areas. All come together to Share or explore their Research works and Ideas, Special welcome to the delegates in all fields to gain or gathering of some information for their future.

What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?

This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.

This seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.

The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) is a non-profit, non-governmental association and has its headquarters in Geneva, Switzerland. ISPPD is the leading event in Pneumococci and Pneumococcal Diseases bringing together professionals in the field to raise global awareness and improve standards of diagnosis, prevention and treatment.

4th International Pharmaceutical Conference and Expo welcome you as our guest to the City of London, UK during August 05-07, 2020. The theme of the upcoming edition of i- Pharma UK  is Pharma research for Industry demands.

The annual i- Pharma conference and expo 2020 is the largest gathering of Pharma and Healthcare professionals in the UK and in Europe. i- Pharma UK is expecting hundreds of academic, research and industry leaders from 24 different countries to gather in London, the UK for this three-day meeting.

i- Pharma Congress 2020 is packed with many workshops, symposiums and multiple plenary sessions with main focus on thought-provoking discussions and peer-led networking. The conference is the ideal venue to learn about the latest trends shaping the pharma industry, to gain new skills and insights from successful pharma experts.

For i- Pharma UK, 2020 renowned academic, researchers along with industry leaders from key pharma companies will be sharing their insights into the role of Drug Discovery,  Drug Designing, Drug Development, Digital Pharma, Pharmacovigilance, Pharma Packaging, Biopharmaceuticals, Drug Delivery Systems and translating this into real life strategies for your career and business.

i- Pharma UK 2020 offers unparalleled business, research opportunities and access to new markets in Pharma and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest.

Join us and witness the booming industry by participating at i- Pharma 2020 UK and give your career and business access to new opportunities from throughout the world.

MEDICAL FAIR ASIA continues to be Southeast Asia's most definitive event for the medical and healthcare industry, gathering the region's hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business.

Following the successful growth path since its inception in 1997, MEDICAL FAIR ASIA will see its most impressive line-up ever of medical and healthcare industry players from around the world in its 13th edition, scheduled to be held from 9 - 11 Sep 2020 at Marina Bay Sands Singapore.

The fifth edition of MEDICAL MANUFACTURING ASIA makes a return to Singapore as the region's leading specialist trade fair for Asia's medtech and medical manufacturing processes sectors.

Jointly organised by SPETA (Singapore Precision Engineering and Technology Association) and Messe Düsseldorf Asia, MEDICAL MANUFACTURING ASIA 2020 will feature an extensive product range covering the upstream and downstream processes in medtech sectors, including new materials, components, intermediate products, packaging and services, to micro and nanotechnology, testing systems and services, as well as materials, substance and components for medical technology. Industry-focused business forums will also headline the upcoming edition of the specialist trade fair.

art of the MEDICAlliance’s global network and sharing the established expertise of COMPAMED, MEDICAL MANUFACTURING ASIA 2020 is co-located with MEDICAL FAIR ASIA 2020 – the No. 1 medical and healthcare exhibition in Southeast Asia with a focus on the equipment and supplies for the hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors.